Latest News


New Treatment

Philanthropic support helping women with gestational diabetes and their babies.

Generous funding provided through the Douglas and Lola Douglas scholarship is strengthening evidence around the long term impacts on children born to mothers with obesity and gestational diabetes. Endocrinologist and Kolling Institute researcher Dr Tessa Weir has been able to continue her valuable research as a result of being awarded the scholarship. “I am incredibly grateful for t.....
Read more

Category: Cardiovascular and Renal Research, New Treatment, Research Excellence

Transforming treatments for those with diabetes .

Kolling researcher and Royal North Shore Hospital endocrinologist Associate Professor Sarah Glastras will have a key role in a national effort to improve long-term outcomes for those with diabetes. The initiative has brought dozens of experts from across the country together under the banner of the Australian Centre for Accelerating Diabetes Innovations Research. International collaborat.....
Read more

Category: Cardiovascular and Renal Research, New Treatment, Research Excellence

Encouraging news for those with chronic kidney disease.

Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock. Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme. The listing aims to help those with the c.....
Read more

Category: Cardiovascular and Renal Research, New Treatment

Researchers investigate if stem cells can reverse osteoarthritis damage .

Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis. The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone. Royal North Shore Hospital rheumatologist Professor David Hunter is leading the two-year trial which is re.....
Read more

Category: Musculoskeletal Research, New Treatment

Ground breaking approach to emergency care in NSW to be tested.

New funding will see a large-scale project launched across NSW to significantly improve patient outcomes and experiences in Emergency Departments. Chief investigator and Kolling Institute researcher Professor Margaret Fry said more than $2.8 million will be invested in the EPIC-START program, giving patients better access to early evidence-based treatment pathways. 30 Emergency Departmen.....
Read more

Category: New Treatment, Research Excellence

Australia to introduce ground breaking technology to target debilitating Mito disease.

Clinicians, researchers and patients have welcomed a landmark law which will pave the way for remarkable new IVF technology to prevent mitochondrial disease. Known as “Maeve’s law” after a young Victorian girl with a rare genetic disorder, the legislation was passed by Federal Parliament allowing the specialised IVF procedure to be carried out in Australia. It will involve replacing faul.....
Read more

Category: Neuroscience and Pain Research, New Treatment, World-leading technology

Researchers identify the best way to ease chronic pain.

With large numbers of people across the community looking for effective and lasting ways to treat pain, our researchers at the Kolling Institute are driving nationally significant projects to reduce a reliance on opioid medication and promote proven alternative options. The research by our team from the Pain Management Research Centre follows the latest figures which indicate around 20 p.....
Read more

Category: Neuroscience and Pain Research, New Treatment, Research Excellence

Researchers develop new program to reduce medication burden  .

A team from the Kolling Institute led by Professor Sarah Hilmer has helped develop a valuable, new national program to reduce the adverse impacts of taking multiple medicines. Medicines with an anticholinergic effect can successfully treat many conditions such as depression, dementia and chronic non-cancer pain. Cumulatively however, they can cause serious adverse effects such as falls, .....
Read more

Category: New Treatment, Research Excellence

Game-changing research partnership to ease musculoskeletal burden.

An important new partnership has been formed to dramatically improve care for musculoskeletal conditions by speeding up the translation of research to clinical practice. The Northern Sydney Local Health District has joined with the University of Sydney and Sydney Local Health District to create Sydney Musculoskeletal Health which will link researchers from across the University with clin.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence

World Spine Day: Kolling researchers challenging old concepts to improve care.

To mark World Spine Day on October 16, the Back Pain Research team at the Kolling Institute is urging those who experience the condition to adopt the latest advice and keep moving. Spinal pain is extremely common, affecting around 800 million people globally. The condition compromises social, family and work activities, and is the main reason Australians retire involuntarily. The lower b.....
Read more

Category: Musculoskeletal Research, New Treatment, Research Excellence